Drug delivery spiral coil construct

• US 9,561,351 B2
• Filed: 05/31/2006
• Issued: 02/07/2017
• Est. Priority Date: 05/31/2006
• Status: Expired due to Fees

• Current Assignee: Advanced Cardiovascular Systems Incorporated (Abbott Laboratories)
• Original Assignee: Advanced Cardiovascular Systems Incorporated (Abbott Laboratories)
• Inventors: Kleine, Klaus, Gale, David C., El-Nounou, Fozan, Hossainy, Syed F. A., Ludwig, Florian
• Primary Examiner(s): TANNER, JOCELIN C
• Application Number:
  US11/445,079
• Publication Number:
  US 20070282425A1
• Time in Patent Office: 3,905 Days
• Field of Search: 623/1.22, 623/1.15, 623/1.16, 623 142- 148, 623 139- 141, 623/1.2, 604/507, 604/508, 604/523, 604/528, 606/194, 606/200, 606/195
• US Class Current: 1/1
• CPC Class Codes: A61F 2/88 the wire-like elements formed as helical or spiral coils forming a net-like or mesh-like structure A61F2/90
• CPC Class Codes: A61F 2/885 comprising a coil including a plurality of spiral or helical sections with alternate directions around a central axis
• CPC Class Codes: A61F 2250/0039 differing in diameter
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body
• CPC Class Codes: A61M 31/002 Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time artificial gland structures or devices A61F2/022; intra-uterine contraceptive devices A61F6/14; tampons for introducing into the vagina A61F13/20, A61L15/00; suppositories or bougies for intra-vaginal or intra-uterine application A61K9/02; physical forms of medicinal preparations for sustained or differential drug release A61K9/20, A61K9/50

Abstract

An implantable medical device is disclosed having a helical construct including a set of spiral coils for local in vivo application of a therapeutic substance in a biological lumen. The helical construct is configured to apply less than 0.75 Bar of pressure to the biological lumen wall. The helical construct can have at least two sets of spiral coils having opposing helical directions. The device can be used for the treatment of vascular disorders such as restenosis and vulnerable plaque.

Claims

1. An implantable medical device, comprising:

a helical construct including a spiral coil and a therapeutic substance for local in vivo application of the therapeutic substance in a biological lumen, wherein the helical construct is configured to apply less than 0.75 Bar of pressure to a wall of the biological lumen when the helical construct is deployed in the biological lumen and after the helical construct is deployed and implanted in the biological lumen, wherein the helical construct is in an expanded configuration, from a reduced configuration, and configured to be in contact with the wall of the biological lumen post deployment and when implanted in the biological lumen, and wherein the helical construct includes a proximal free end and a distal free end, both ends which are configured to be positioned in the biological lumen when the helical construct is expanded and implanted.

2. The implantable medical device of claim 1 wherein the pressure is less than 0.5 Bar.

3. The implantable medical device of claim 1 wherein the pressure is less than 0.25 Bar.

4. The implantable medical device of claim 1 wherein the pressure is less than 0.2 Bar.

5. The implantable medical device of claim 1 wherein the pressure is less than 0.1 Bar.

6. The implantable medical device of claim 1 wherein a coil pitch of the helical construct is from about 0.15 mm to about 10 mm.

7. The implantable medical device of claim 1 wherein the helical construct has a variable coil pitch.

8. The implantable medical device of claim 1 wherein the helical construct comprises a proximal segment, a distal segment, and a middle segment there between, and wherein a coil pitch of the proximal segment is different than a coil pitch of the middle segment and/or a coil pitch of the distal segment is different than a coil pitch of the middle segment.

9. The implantable medical device of claim 8 wherein the coil pitch of the proximal segment or distal segment is greater than the coil pitch of the middle segment.

10. The implantable medical device of claim 1 wherein the helical construct is shaped to have a coil contact angle of 0 to 80 degrees.

11. The implantable medical device of claim 1 wherein the helical construct is shaped to have a coil contact angle of 10 to 70 degrees.

12. The implantable medical device of claim 1 wherein the helical construct includes a first set and a second set of spiral coils such that the first set of spiral coils has a counter helical configuration than the second set of spiral coils.

13. The implantable medical device of claim 12 wherein the first set of spiral coils is connected to the second set of spiral coils by a V-shaped or U-shaped connector.

14. The implantable medical device of claim 12 wherein the first set of spiral coils is connected to the second set of spiral coils with a polymeric connector.

15. The implantable medical device of claim 12 wherein the first set of spiral coils is connected to the second set of spiral coils with a biodegradable connector.

16. The implantable medical device of claim 12 wherein the device includes two different therapeutic substances such that the first set of spiral coils carries a first therapeutic substance and the second set of spiral coils carries a second therapeutic substance.

17. The implantable medical device of claim 12 wherein the first set of spiral coils is made of a different material than the second set of spiral coils.

18. The implantable medical device of claim 12 wherein the first set of spiral coils carries a different amount of the therapeutic substance than the second set of spiral coils.

19. The implantable medical device of claim 1 wherein the helical construct is made from a polymeric material.

20. The implantable medical device of claim 1 wherein the helical construct is made from a biodegradable polymeric material.

21. The implantable medical device of claim 1 wherein the helical construct is made from a biodegradable polymeric material and a bioerodable metallic material.

22. The implantable medical device of claim 1 wherein the therapeutic substance is embedded within or coated on the helical construct.

23. The implantable medical device of claim 1 wherein the length of the helical construct is at least 40 mm.

24. The implantable medical device of claim 1 wherein the helical construct is self-expandable.

25. The implantable medical device of claim 1 wherein the helical construct comprises a first end segment, a second end segment and a middle segment there between, such that the first end segment has a coil pitch that is greater than the second end segment.

26. The implantable medical device of claim 1 wherein the helical construct is shaped to have a coil angle of 20 to 60 degrees.

27. The implantable medical device of claim 1 wherein the helical construct comprises a proximal coil segment, a distal coil segment, and a middle coil segment there between, and wherein the middle coil segment has a counter helical configuration than both the proximal and distal coil segments.

28. The implantable medical device of claim 27 wherein the length of each of the proximal and distal coil segments is less than the length of the middle coil segment.

29. The implantable medical device of claim 1 wherein the helical construct is made of a metallic material.

30. The implantable medical device of claim 1 wherein the helical construct is made of a biodegradable metallic material.

31. The implantable medical device of claim 1 wherein the helical construct includes a metallic core with a polymer shell enclosing the core.

32. The implantable medical device of claim 1 wherein the helical construct comprises a polymer having metallic particles.

33. The implantable medical device of claim 1 further comprising micro- or nano-particles, embedded within the helical construct or coated on the helical construct, the micro- or nano-particles carrying the therapeutic substance for in vivo delivery.

34. The implantable medical device of claim 1 wherein the therapeutic substance is rapamycin, 40-O-(2-hydroxy)ethyl-rapamycin (everolimus), 40-epi-(N1-tetrazolyl)-rapamycin, 40-O-(3-hydroxy)propyl-rapamycin, 40-O-[2-(2-hydroxy)ethoxy]ethyl-rapamycin, 40-O-tetrazole-rapamycin, paclitaxel or docetaxel.

35. The implantable medical device of claim 1 wherein the helical construct comprises a shape memory material.

36. The implantable medical device of claim 1 additionally including a delivery catheter on which the helical construct is crimped such that segments of the coil overlap one another when the construct is in a crimped configuration on the catheter.

37. A method of treating a vascular disorder comprising implanting the device of claim 1 in a human patient, such that the device of claim 1 applies less than 0.75 Bar of pressure on to the wall of the biological lumen when implanted in the expanded configuration and in contact with the wall of the biological lumen, wherein implanting is by a delivery device such that the device of claim 1 is left behind in the biological lumen after withdrawal of the delivery device.

38. The method of claim 37 wherein the disorder is vulnerable plaque.

39. The method of claim 37 wherein the disorder is restenosis.

40. The method of claim 37 wherein the device does not maintain patency of a vessel in which the device is implanted.

41. The method of claim 37 wherein post implantation, the device is maintained in an exact vicinity or a general vicinity of a site of implantation with little to no post implantation movement of the device for a selected duration of time for the application of a quantity of the therapeutic substance.

42. The method of claim 37 wherein the device does not inflict trauma on a lumen wall at a site of implantation.

43. The method of claim 37 wherein the device does not cause hyper-proliferation and migration of vascular smooth muscle cells at a site of implantation.

44. The method of claim 37 additionally comprising delivering a viscous solution containing a biologically benign matrix and a therapeutic agent to a site of implantation.

45. The method of claim 44 wherein the viscous solution acts as a lubricant for smooth delivery of the helical construct and provides for biological therapy to the site of implantation of the helical construct.

46. The method of claim 37 additionally comprising delivering a solution including an amphiphilic, surface active molecule to a site of implantation to change a mechanical property of a material from which the helical construct is made.

47. The method of claim 37 additionally comprising delivering a solution to a site of implantation for increasing conformation of the helical construct to a vessel wall in contact with the helical construct.

48. The method of claim 37 additionally comprising delivering a solution to a site of implantation for changing a property of a material from which the helical construct is made or changing a release profile of the therapeutic substance, wherein the solution has a viscosity not less than 5 centipoise.

49. The method of claim 48 wherein the viscosity is not less than 10 centipoise.